Category: News Well
Content tagged to appear in the middle column of the home page
AngioDynamics names Joseph DeVivo as its new CEO, replacing Jan Keltjens, and reveals the departure of one of its senior business development executives.
AngioDynamics Inc. (NSDQ:ANGO) named a replacement for former CEO Jan Keltjens, who left suddenly in June, tapping Joseph DeVivo for the corner office.
The Latham, N.Y.-based oncology device company also revealed the resignation of senior vice president of business development Lynda Wallace, according to SEC filings.
A new Gallup poll shows that American's opinion of the FDA is on the upswing
American's view of the FDA are improving, according to a recent Gallup survey of opinions on federal agencies.
The federal watchdog agency received a net positive rating of 24%, according to the polling organization, putting it ahead of The Department of Homeland Security, Federal Reserve, Environmental Protection Agency and the Internal Revenue Service.
Medtronic finishes enrolling patients in a U.S. trial of its Simplicity renal denervation system to treat high blood pressure
Medtronic (NYSE:MDT) has wrapped up patient enrollment in its Symplicity HTN-3 trial to evaluate company's renal denervation system and support U.S. approval.
Volcano and Boston Scientific use their respective devices simultaneously for more accurate stent placement in a new study announced at EuroPCR
Volcano Corporation (NSDQ:VOLC) and Boston Scientific (NYSE:BSX) announced a new, cosponsored Syntax study to test precision in stent placement.
The companies announced the upcoming study at the EuroPCR annual meeting in Paris, France.
St. Jude presents 1-year data supporting its EnligHTN device for patients with drug-resistant high blood pressure
St. Jude Medical (NYSE:STJ) released results for its EnligHTN renal denervation system trial, which effectively lowered blood pressure in patients after 1 year.
Data from EnliGHTN I was presented at the annual EuroPCR meeting in Paris, France.
Jurors in Washington state vote 10-2 for Intuitive Surgical in the first of many lawsuits over the company's da Vinci robotic surgical system
Intuitive Surgical (NSDQ:ISRG) won a legal victory in a patient injury lawsuit involving its da Vinci robotic surgical assist device.
Aussie regulators give the green light to FizioMed's Dynavisc, an absorbable gel applied to tendons and nerves after surgery.
Privately held medical device maker FzioMed won Australian regulatory approval for its Dynavisc post-surgical gel, an absorbable gel applied to tendons and nerves to reduce adverse events after surgery.
The San Luis Obispo, Calif.-based company said the product is similar to Medtronic's (NYSE:MDT) Medishield, which has been on the market for more than 70 years.
